07/25 1623  |  Dow  11,370.69    21.4  |  Nasdaq  2,310.53    30.4  |  Russell 2000  710.30    7.9  |  S&P 500  1,257.76    5.2  |  AMEX  2,152.01    27.6
Dutton Associates Home Page About Dutton Associates Covered Companies Research Alerts Our Analysts Contact Us Email Sign Up
 
 
Arcadia Resources, Inc.
Market Information
Symbol: KAD
Exchange: AMEX
Industry: Healthcare, Biotechnology & Pharmaceutical
Analyst
Denise T. Resnik, M.S.
Dutton Associates Rating
Speculative Buy
Rating Information
Recent Price: $0.38 (7/24/2008)
Price Target: $0.87
Established: 5/27/2008
Price at Rating: $0.76
Time Frame: 12 Months
Other Information
 
Dutton Associates' Research on Arcadia Resources, Inc. (PDF format)
06/25/2008 Research Note Arcadia Resources Estimate Adjustment; Reiterate Speculative Buy Rating Speculative Buy
06/17/2008 Research Note Arcadia Resources Announces Fourth Quarter and Year-End Results; Reiterate Speculative Buy Rating Speculative Buy
05/27/2008 Update Report Arcadia Speculative Buy Rating In Updated Coverage; Significantly Higher Share Valuations Could Be Envisioned Speculative Buy
03/19/2007 Research Note Arcadia Resources - Well-positioned to Benefit from Ongoing Changes in U.S. Healthcare - 60% Upside - Upgrade to BUY Buy
10/13/2006 Research Note Arcadia (KAD) - Walk-in Medical Clinic Business Could be a Significant Expansion - Maintain Neutral Neutral
09/13/2006 Update Report Arcadia Resources Neutral Rating On Price In Updated Coverage; Long Been A Significant Player In Healthcare Staffing And Durable Medical Equipment, With New Alternative Channels Such As Mass-Market Retailers Neutral
06/08/2006 Research Note Arcadia Resources Announces Creative Initiative to Staff Non-emergency Medical Clinics in Michigan; Building on Sears Initiative; Buy Rating Reiterated Buy
04/03/2006 Initial Report Arcadia Resources Buy Rating Maintained In Updated Initial Coverage; National Player in Two of the Most Attractive Areas in the Medical Field Buy
03/17/2006 Research Note Arcadia Resources - Share Price Strength Limits Upside - Raising Price Target; Lowering Rating from Buy to Neutral; No Diminished Enthusiasm for Arcadia's Business Model and Prospects Neutral
02/14/2006 Research Note Arcadia Resources - Two Acquisitions Continue Strategy to Expand in High-margin DME Business - Reiterate Strong BUY Strong Buy
11/15/2005 Research Note Arcadia Resources Posts Strong Results; Non-cash Charges Hurt Bottom-line - Reiterate Strong Buy Rating and $3.50 Price Target Strong Buy
11/01/2005 Update Report Arcadia Resources Strong Buy Rating Maintained In Update Coverage; Significant Player in Two Very Attractive Sections of the Health Care Arena Strong Buy
10/05/2005 Research Note Arcadia Resources Opens Home Health Care Product Stores in Six Sears Locations in Detroit - Reiterate Strong Buy Strong Buy
10/03/2005 Research Note Arcadia Resources Raises $30 Million in Major Financing; Use of Proceeds Not Identified; Reiterate Strong Buy Rating and $4.00 Price Target Strong Buy
09/26/2005 Research Note Arcadia Resources Closes Financing Raising $1 Million through Sale of Warrants; Reiterate Strong Buy Strong Buy
08/28/2005 Research Note Arcadia Resources: Acquisition in Florida Continues Strategy of In-home Health Care Products and Services Expansion - Strong Buy Strong Buy
08/18/2005 Research Note Arcadia Resources - Results In-line with Our Expectations; Gross Margin Improvement Sets the Stage for Solid Profitability - Reiterate Strong Buy and $4.00 Price Target Strong Buy
07/27/2005 Research Note Arcadia Resources - Raising Estimates for FY06 and FY07 - Raising Price Target to $4.00 - Reiterate Strong Buy Strong Buy
07/19/2005 Research Note Arcadia Resources - Florida Acquisition to Expand High Margin In-home Health Care Business - Reiterate Strong Buy Strong Buy
07/07/2005 Research Note ACDI - Extra Expenses Hide Solid 4Q Growth and Trends - Reiterate STRONG BUY Strong Buy
06/20/2005 Research Note Arcadia Resources Buys Right to Market 'Sears Shop at Home' Health & Wellness Products' - Reiterate STRONG BUY Strong Buy
06/08/2005 Research Note Arcadia Looks Increasingly Interesting As Home Healthcare Acquisitions Drive Stocks - STRONG BUY Rating Reiterated Strong Buy
06/01/2005 Research Note Arcadia Acquires Chicago-area DME Business and Hires UBS as Financial Advisor to Source Additional Deals - Maintain Strong Buy Strong Buy
05/02/2005 Research Note Arcadia Resources Inc. Announces Acquisition; Reiterate Strong Buy Rating Strong Buy
04/15/2005 Research Note Arcadia Resources Durable Medical Equipment Acquisition - Recent Weakness Unjustified - Reiterate BUY Strong Buy
04/01/2005 Update Report Arcadia Resources Inc. Strong Buy Rating Maintained; Look for Improvement in Coming Quarters Strong Buy
03/23/2005 Research Note Arcadia Signs Deal with Sears to Sell Durable Medical Equipment in Sears Stores - Best Possible Partner for this High Margin Business - Raising Price Target to $2.75 - Strong Buy Rating Reiterated Strong Buy
03/22/2005 Research Note Arcadia Contracts to Provide Staffing Services to the U.S. Veterans Administration - Reiterate Strong Buy Strong Buy
02/16/2005 Research Note Arcadia Resources - Raising Our Rating To Strong Buy And Our Price Target to $2.40; Solid Results and Improving Execution - Strong Buy
02/14/2005 Research Note Arcadia Resources Reports Strong Dec Qtr Results - 13% Organic Growth and Better than Expected Gross Margins - Reiterate BUY Buy
02/13/2005 Research Note Arcadia Resources: Raises Profile - Reiterate Buy and Price Target Buy
02/10/2005 Research Note Arcadia Resources Raises $3.5 million for Acquisitions and New Ventures - Reiterate BUY Buy
01/10/2005 Research Note Arcadia Adds CFO with Experience Building Companies in the Healthcare Staffing and DME Industry - Raising Target Price - Reiterate BUY Buy
12/29/2004 Research Note Arcadia Acquisition of Respiratory Business Highlights Growth Trend - Reiterate BUY Buy
12/22/2004 Research Note Sector Comments: Aging of America and Its Impact - Summary Review On Arcadia Resources, World Health Alternatives, and IntegraMed America Buy
12/20/2004 Research Note Arcadia Resources: Decision to Delay Announcement of Medicare Oxygen Reimbursement Rates for 2005 is Good for Arcadia and other DME Players - BUY Buy
12/01/2004 Update Report Arcadia Resources Buy Rating Reiterated in Update; Excellent Play On The Aging Of The U.S. Population And Increased Spending On Healthcare Buy
11/16/2004 Research Note Critical Home (Name Change to Arcadia Resources) - 3Q04 Results In-line with Estimates - Reiterate Buy Buy
10/29/2004 Initial Report Critical Home Care, Inc. Buy Rating in Initiating Coverage; Significant Player in Attractive Areas of Healthcare Business Buy

Current Dutton Associates disclaimer and 17b disclosure information regarding Arcadia Resources, Inc.

Information, opinions or recommendations contained in Dutton Associates' research reports or research notes are submitted solely for advisory and information purposes. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Such information and the opinions expressed are subject to change without notice. A Dutton Associates research report or note is not intended as an offering or a solicitation of an offer to buy or sell the securities mentioned or discussed.  The Firm does not accept any equity compensation. Anyone may enroll a company for research coverage, which currently costs US $35,000 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $63,000 from the Company for 8 Research Reports with coverage commencing on 10/29/2004. Reports are performed on behalf of the public, and are not a service to any company. The analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests and insure independence. Please read full disclosure and other reports and notes on the Company at www.DuttonAssociates.com.

The views expressed in this research report or note accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by Dutton Associates is in any way related to the specific recommendations or views contained in this research report or note.

Dutton Associates. John M. Dutton, President, 3721 Douglas Blvd., Suite 350, Roseville, CA 95661 Phone (916) 960-0623, Fax (916) 960-0641.

Periodic Research Reports and Research Notes on this Company are available at our web site: www.DuttonAssociates.com.

© Copyright 2008, by Dutton Associates